BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27

• FDA

  Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) Crumbles as FDA Wants More Testing Of Muscular Disease Drug Eteplirsen; Stock Down -64.01% At Market Close (November 12, 2013)

  November 12, 2013

   · 

  9 min read
• Policy

  Sanofi Files “First-Of-A-Kind” Lawsuit Against FDA Over OTC Drug

  November 12, 2013

   · 

  1 min read
• Drug Development

  GlaxoSmithKline Heart Drug Misses Goal In Major Study

  November 12, 2013

   · 

  1 min read
• Policy

  Vanda Pharmaceuticals, Inc.'s Experimental Drug Helps The Blind Sleep, FDA Staff Says; Stock Soars +95.93% At Market Close (November 12, 2013)

  November 12, 2013

   · 

  1 min read
• Business

  Scanadu Secures $10.5 Million In Series A To Make Its Medical Tricorder A Reality

  November 12, 2013

   · 

  5 min read
• Policy

  Boston Scientific Corporation’s Anti-Stroke Watchman Heart Implant Lands A Date With The FDA

  November 12, 2013

   · 

  1 min read
• Job Trends

  Solta Medical, Inc. To Reduce Workforce, Explore Sale In Restructuring

  November 12, 2013

   · 

  1 min read
• Business

  Envisia Therapeutics Debuts With $25 Million Series A Financing

  November 12, 2013

   · 

  3 min read
• Job Trends

  Dendreon Corporation Slashes 15 Percent Of Jobs As Provenge Sales Disappoint

  November 12, 2013

   · 

  1 min read
• Drug Development

  PsiOxus Therapeutics Limited Cancer-Wasting Drug Better Than Placebo In Phase 2 Study

  November 12, 2013

   · 

  4 min read